Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-07-11
1979-12-25
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260506, A61K 31185, C07C14330
Patent
active
041805879
ABSTRACT:
A method of inhibiting the complement system in a warm-blooded animal which comprises the administration of a ureylenebis-[substituted-phenylenecarbonyl (and sulfonyl) imino-substituted-phenylene carbonylimino-naphthalenetrisulfonic acid, hexaalkali metal salt].
REFERENCES:
patent: 4046805 (1977-09-01), Bernstein
patent: 4051176 (1977-09-01), Bernstein
patent: 4087548 (1978-05-01), Lenhard
Bernstein Seymour
Conrow Ransom B.
Poletto John F.
Siuta Gerald J.
American Cyanamid Company
Caroli Claude J.
Fagelson Anna P.
LandOfFree
Ureylene phenylene anionic naphthalenesulfonic acids as compleme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ureylene phenylene anionic naphthalenesulfonic acids as compleme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ureylene phenylene anionic naphthalenesulfonic acids as compleme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2070638